Skip to main content
. Author manuscript; available in PMC: 2011 Nov 16.
Published in final edited form as: Circulation. 2010 Nov 1;122(20):2016–2021. doi: 10.1161/CIRCULATIONAHA.110.948828

Table 3a.

SNPs with P<10−5 in the adjusted analysis*

CHR SNP Gene Allele MAF BETA (ms) SE (ms) L95 U95 P value
3 rs6800541 SCN10A C 0.414 2.517 0.502 1.533 3.500 5.73×10−7
3 rs6795970 SCN10A A 0.407 2.505 0.504 1.517 3.493 7.26×10−7
10 rs1937332 Intergenic1 G 0.466 2.453 0.497 1.479 3.426 8.45×10−7
2 rs17034876 Intergenic2 C 0.292 2.707 0.552 1.625 3.788 1.00×10−6
3 rs6798015 SCN10A C 0.380 2.485 0.513 1.479 3.491 1.36×10−6
3 rs7430477 SCN10A T 0.473 −2.361 0.493 −3.328 −1.395 1.78×10−6
11 rs1893057 Intergenic3 G 0.299 2.483 0.538 1.428 3.538 4.21×10−6
11 rs1940163 MAML2 A 0.321 2.406 0.527 1.374 3.439 5.22×10−6
10 rs2251050 Intergenic1 T 0.373 −2.316 0.510 −3.315 −1.317 5.80×10−6
9 rs1889318 ASTN2 C 0.428 2.239 0.497 1.265 3.212 6.94×10−6
10 rs1317361 Intergenic1 G 0.418 −2.233 0.499 −3.210 −1.256 7.84×10−6
*

adjusted for age, sex, use of PR-active medications, and the first three principle components from Eigenstrat.

Abbreviations as in Table 2.

1

between FAS/ CH25H

2

between PRKCE/ EPAS1

3

between MTMR2/ MAML2

4

between C18orf20 and LOC643448

5

between RNF19A and ANKRD46